Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.7 - $37.13 $1.1 Million - $5.32 Million
-143,297 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$26.46 - $37.15 $3.79 Million - $5.32 Million
143,297 New
143,297 $4.87 Million
Q3 2020

Nov 16, 2020

SELL
$43.8 - $58.16 $11 Million - $14.5 Million
-250,133 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $1.62 Million - $2.85 Million
43,797 Added 21.23%
250,133 $14.9 Million
Q1 2020

May 15, 2020

BUY
$33.63 - $69.4 $6.94 Million - $14.3 Million
206,336 New
206,336 $8.5 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.